查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1598814

疫苗管瓶市场：按类型、材料、容量和应用分类 - 2025-2030 年全球预测

Vaccine Vials Market by Type (Multi Dose, Single Dose), Material (Glass, Polymer), Capacity, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年疫苗管瓶市值为6.2996亿美元，预计到2024年将达到6.9772亿美元，复合年增长率为10.84%，到2030年将达到12.9547亿美元。

疫苗管瓶市场包括用于储存疫苗的小玻璃或塑胶容器的生产和分销。这些管瓶对于维持疫苗功效、确保安全有效的交付以及适应储存物流至关重要。疫苗管瓶的需求源于其在保护疫苗功效、促进安全运输以及在疫苗接种过程中提供精确剂量方面的作用。其应用涵盖医院、诊所和实验室等各种最终用途部门。主要成长动力包括感染疾病的日益普及、针对新出现的健康威胁（例如 COVID-19）的疫苗开发进展以及全球免疫计画的加强。此外，製造流程的技术进步可以实现更安全、更有效率的管瓶生产，这提供了一个有吸引力的机会。与製药公司在创新包装解决方案方面的合作可能会进一步巩固市场地位。然而，市场成长面临严格的监管要求、高製造成本以及可能阻碍扩张的供应链中断等挑战。对永续包装不断增长的需求迫使製造商利用环保材料进行创新，并突显了潜在的研发领域。探索生物分解性和可回收材料，提高低温运输物流效率将为创新铺平道路。此外，开发包含温度感测器等数位功能的智慧管瓶也存在机会，以提高疫苗储存的完整性。这些创新有可能透过解决当前市场限制并与永续性目标保持一致来开拓新市场并加强现有营运。市场动态呈现出一种竞争格局，在快速变化的公共卫生需求中，持续创新对于维持相关性至关重要。总之，优先研究永续包装材料与智慧管瓶技术相结合可以实现长期业务成长，同时满足製药业面临的高需求和营运挑战。

主要市场统计
基准年[2023] 6.2996 亿美元
预测年份 [2024] 6.9772 亿美元
预测年份 [2030] 12.9547亿美元
复合年增长率（%） 10.84%

市场动态：快速发展的疫苗管瓶市场的关键市场洞察

供需的动态交互作用正在改变疫苗管瓶市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 感染疾病流行和疫苗需求增加
    • 政府机构和私人组织加强促进疫苗接种
  • 市场限制因素
    • 缺乏医疗基础设施
  • 市场机会
    • 人们越来越偏好高效能包装解决方案
    • VVM 对确保疫苗安全的重要性日益增加
  • 市场挑战
    • 与疫苗管瓶供应链相关的高成本

波特的五力：驾驭疫苗管瓶市场的策略工具

波特的五力框架是了解疫苗管瓶市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解疫苗管瓶市场的外部影响

外部宏观环境因素在塑造疫苗管瓶市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解疫苗管瓶市场的竞争状况

疫苗管瓶市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵疫苗管瓶市场供应商的绩效评估

FPNV 定位矩阵是评估疫苗管瓶市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了疫苗管瓶市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，对疫苗管瓶市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 感染疾病蔓延与疫苗需求旺盛
      • 政府和私人组织正在加强促进疫苗接种。
    • 抑制因素
      • 缺乏医疗基础设施
    • 机会
      • 人们对高性能包装解决方案的兴趣日益浓厚
      • VVM 对确保疫苗安全的重要性日益增加
    • 任务
      • 与疫苗管瓶供应链相关的高成本
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章疫苗管瓶市场：依类型

  • 多剂量
  • 单一剂量

第七章疫苗管瓶市场：依材料分类

  • 玻璃
  • 聚合物

第八章疫苗管瓶市场：依容量分类

  • 10ml
  • 20ml
  • 2ml
  • 3ml
  • 5ml

第九章疫苗管瓶市场：依应用分类

  • 预防性疫苗
  • 治疗性疫苗

第10章美洲疫苗管瓶市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太疫苗管瓶市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲疫苗管瓶市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Cardinal Health, Inc.
  • Catalent, Inc.
  • Corning Incorporated
  • DWK Life Sciences GmbH
  • Elitech Technology, Inc.
  • ELPRO-BUCHS AG
  • EVIGENCE SENSORS Inc.
  • Gerresheimer AG
  • Lisaline Lifescience Technologies Pvt Ltd.
  • Nipro Corporation
  • Pacific Vial Manufacturing Inc.
  • Schott AG
  • Stevanato Group
  • Temptime Corporation by Zebra Technologies Corporation
  • Thermo Fisher Scientific Inc.
Product Code: MRR-F74E250AD5FF

The Vaccine Vials Market was valued at USD 629.96 million in 2023, expected to reach USD 697.72 million in 2024, and is projected to grow at a CAGR of 10.84%, to USD 1,295.47 million by 2030.

The vaccine vials market encompasses the production and distribution of small glass or plastic containers used to store vaccines. These vials are crucial for maintaining vaccine potency, ensuring safe and effective delivery, and accommodating storage logistics. The necessity of vaccine vials stems from their role in safeguarding vaccine potency, facilitating safe transportation, and delivering precise doses during vaccination processes. Their application spans across various end-use sectors, including hospitals, clinics, and research laboratories. Key growth drivers include the increasing prevalence of infectious diseases, ongoing vaccine development due to emerging health threats such as COVID-19, and robust immunization programs globally. Additionally, technological advancements in manufacturing processes, enabling safer and more efficient vial production, represent compelling opportunities. Collaborations with pharmaceutical companies for innovative packaging solutions can further strengthen market position. However, market growth faces challenges like stringent regulatory requirements, high manufacturing costs, and supply chain disruptions that could impede expansion. The rise in demand for sustainable packaging places pressure on manufacturers to innovate with eco-friendly materials, highlighting potential areas for research and development. Exploring biodegradable and recyclable materials, and improving the efficiency of the cold chain logistics, presents avenues for innovation. Moreover, there's an opportunity in the development of smart vials incorporating digital features, like temperature sensors, to enhance the integrity of vaccine storage. These innovations can potentially open new markets and enhance existing operations by addressing current market limitations and aligning with sustainability goals. Market dynamics indicate a competitive landscape where constant innovation is crucial for staying pertinent amid rapidly evolving public health needs. In conclusion, prioritizing research in sustainable packaging materials coupled with smart vial technology can provide long-term business growth while meeting the high-demand requirements and operational challenges faced in the pharmaceutical industry.

KEY MARKET STATISTICS
Base Year [2023] USD 629.96 million
Estimated Year [2024] USD 697.72 million
Forecast Year [2030] USD 1,295.47 million
CAGR (%) 10.84%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Vaccine Vials Market

The Vaccine Vials Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • High prevalence of infectious diseases and demands for number of vaccines
    • Growing initiatives from government and private organizations to advance vaccination
  • Market Restraints
    • Lack of healthcare infrastructure
  • Market Opportunities
    • Rising preference for high performance packaging solutions
    • Increasing importance of vvm to ensure vaccine safety
  • Market Challenges
    • High-cost associated with the supply chain of vaccine vials

Porter's Five Forces: A Strategic Tool for Navigating the Vaccine Vials Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Vaccine Vials Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Vaccine Vials Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Vaccine Vials Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Vaccine Vials Market

A detailed market share analysis in the Vaccine Vials Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Vaccine Vials Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Vaccine Vials Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Vaccine Vials Market

A strategic analysis of the Vaccine Vials Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Vaccine Vials Market, highlighting leading vendors and their innovative profiles. These include Cardinal Health, Inc., Catalent, Inc., Corning Incorporated, DWK Life Sciences GmbH, Elitech Technology, Inc., ELPRO-BUCHS AG, EVIGENCE SENSORS Inc., Gerresheimer AG, Lisaline Lifescience Technologies Pvt Ltd., Nipro Corporation, Pacific Vial Manufacturing Inc., Schott AG, Stevanato Group, Temptime Corporation by Zebra Technologies Corporation, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Vaccine Vials Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Multi Dose and Single Dose.
  • Based on Material, market is studied across Glass and Polymer.
  • Based on Capacity, market is studied across 10ml, 20ml, 2ml, 3ml, and 5ml.
  • Based on Application, market is studied across Preventive Vaccine and Therapeutic Vaccine.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. High prevalence of infectious diseases and demands for number of vaccines
      • 5.1.1.2. Growing initiatives from government and private organizations to advance vaccination
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of healthcare infrastructure
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising preference for high performance packaging solutions
      • 5.1.3.2. Increasing importance of vvm to ensure vaccine safety
    • 5.1.4. Challenges
      • 5.1.4.1. High-cost associated with the supply chain of vaccine vials
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Vaccine Vials Market, by Type

  • 6.1. Introduction
  • 6.2. Multi Dose
  • 6.3. Single Dose

7. Vaccine Vials Market, by Material

  • 7.1. Introduction
  • 7.2. Glass
  • 7.3. Polymer

8. Vaccine Vials Market, by Capacity

  • 8.1. Introduction
  • 8.2. 10ml
  • 8.3. 20ml
  • 8.4. 2ml
  • 8.5. 3ml
  • 8.6. 5ml

9. Vaccine Vials Market, by Application

  • 9.1. Introduction
  • 9.2. Preventive Vaccine
  • 9.3. Therapeutic Vaccine

10. Americas Vaccine Vials Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Vaccine Vials Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Vaccine Vials Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Cardinal Health, Inc.
  • 2. Catalent, Inc.
  • 3. Corning Incorporated
  • 4. DWK Life Sciences GmbH
  • 5. Elitech Technology, Inc.
  • 6. ELPRO-BUCHS AG
  • 7. EVIGENCE SENSORS Inc.
  • 8. Gerresheimer AG
  • 9. Lisaline Lifescience Technologies Pvt Ltd.
  • 10. Nipro Corporation
  • 11. Pacific Vial Manufacturing Inc.
  • 12. Schott AG
  • 13. Stevanato Group
  • 14. Temptime Corporation by Zebra Technologies Corporation
  • 15. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. VACCINE VIALS MARKET RESEARCH PROCESS
  • FIGURE 2. VACCINE VIALS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL VACCINE VIALS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL VACCINE VIALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL VACCINE VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL VACCINE VIALS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL VACCINE VIALS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL VACCINE VIALS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL VACCINE VIALS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS VACCINE VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS VACCINE VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES VACCINE VIALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES VACCINE VIALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. VACCINE VIALS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. VACCINE VIALS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. VACCINE VIALS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL VACCINE VIALS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL VACCINE VIALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL VACCINE VIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. VACCINE VIALS MARKET DYNAMICS
  • TABLE 7. GLOBAL VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL VACCINE VIALS MARKET SIZE, BY MULTI DOSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL VACCINE VIALS MARKET SIZE, BY SINGLE DOSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL VACCINE VIALS MARKET SIZE, BY GLASS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL VACCINE VIALS MARKET SIZE, BY POLYMER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL VACCINE VIALS MARKET SIZE, BY 10ML, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL VACCINE VIALS MARKET SIZE, BY 20ML, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL VACCINE VIALS MARKET SIZE, BY 2ML, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL VACCINE VIALS MARKET SIZE, BY 3ML, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL VACCINE VIALS MARKET SIZE, BY 5ML, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL VACCINE VIALS MARKET SIZE, BY PREVENTIVE VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL VACCINE VIALS MARKET SIZE, BY THERAPEUTIC VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS VACCINE VIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES VACCINE VIALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. VACCINE VIALS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 191. VACCINE VIALS MARKET, FPNV POSITIONING MATRIX, 2023